Blogs

<p>Asian equities gained as investors shrugged off worries regarding the escalating US-China tensions and raised their hopes on a potential Covid vaccine proposed by the American biotech company Novavax, which has just started human tests. </p> <p> </p> <p>The Nikkei and ASX 200 rallied 2.63% and 2.32% respectively. Ha

<p>Pivot</p> <p>&nbsp;(invalidation): 33.25 </p> <p>Our preference</p> <p>Long positions above 33.25 with targets at 34.65 &amp; 35.10 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 17.1300 </p> <p>Our preference</p> <p>Long positions above 17.1300 with targets at 17.5700 &amp; 17.7500 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 1725.00 </p> <p>Our preference</p> <p>Long positions above 1725.00 with targets at 1742.00 &amp; 1748.00 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 2935.00 </p> <p>Our preference</p> <p>Long positions above 2935.00 with targets at 2979.00 &amp; 3003.00 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 11245.00 </p> <p>Our preference</p> <p>Long positions above 11245.00 with targets at 11450.00 &amp; 11600.00 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 6.7950 </p> <p>Our preference</p> <p>Long positions above 6.7950 with targets at 6.8250 &amp; 6.8400 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 0.6535 </p> <p>Our preference</p> <p>Long positions above 0.6535 with targets at 0.6575 &amp; 0.6595 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 1.3980 </p> <p>Our preference</p> <p>Short positions below 1.3980 with targets at 1.3935 &amp; 1.3915 in extension.</p> <p>Alternative scenario</p>

<p>Pivot</p> <p>&nbsp;(invalidation): 0.9720 </p> <p>Our preference</p> <p>Short positions below 0.9720 with targets at 0.9700 &amp; 0.9690 in extension.</p> <p>Alternative scenario</p>